In focus · trending topic

Duke Universtiy

1 stories · following the connections

Axsome Therapeutics Collaborates with World-Leading Nicotine Addiction Research Center for Phase 2 Trial of AXS-05 in Smoking Cessation

By Nasdaq OMXDec 14, 2017, 12:00 PM UTC